Related references
Note: Only part of the references are listed.Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
Camilla Salvagno et al.
NATURE CELL BIOLOGY (2019)
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Shang-Hung Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Global Epidemiology of Lung Cancer
Julie A. Barta et al.
ANNALS OF GLOBAL HEALTH (2019)
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation
Wanjing Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGF1 signaling loop in esophageal squamous cell carcinoma
Hongfang Zhang et al.
MOLECULAR CARCINOGENESIS (2017)
Cancer immunotherapy targeting the CD47/SIRPα axis
Kipp Weiskopf
EUROPEAN JOURNAL OF CANCER (2017)
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Hanke L. Matlung et al.
IMMUNOLOGICAL REVIEWS (2017)
Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy
Yuting Huang et al.
JOURNAL OF THORACIC DISEASE (2017)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Recent Clinical Advances in Lung Cancer Management
David H. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The Relationship between the Antitumor Effect of the IL-12 Gene Therapy and the Expression of Th1 Cytokines in an HPV16-Positive Murine Tumor Model
Flor Garcia Paz et al.
MEDIATORS OF INFLAMMATION (2014)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
E. Sick et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
\Generation of Mature Murine Monocytes from Heterogeneous Bone Marrow and Description of Their Properties
Alexander Francke et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy
M Feili-Hariri et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
F Fossella et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
DNA repair and cisplatin resistance in non-small-cell lung cancer
R Rosell et al.
LUNG CANCER (2002)
Platinum drugs in the treatment of non-small-cell lung cancer
J Cosaert et al.
BRITISH JOURNAL OF CANCER (2002)
Integrin-associated protein (CD47) and its ligands
EJ Brown et al.
TRENDS IN CELL BIOLOGY (2001)
The tumor microenvironment as a determinant of cancer cell survival:: a possible mechanism for de novo drug resistance
KH Shain et al.
CURRENT OPINION IN ONCOLOGY (2000)
Share Paper
